A consecutive series of diet pills speed diet 65 obese out-patients aged 18-65 years, with a body mass index (BMI) > 30 diet pills kg/m2, was treated for 6 months with Sertraline HCL ( Zoloft )150 mg/day per os, in addition diet pills to a cognitive-behavioral treatment (CBT). Sertraline HCL ( Zoloft ), a SSRI used in the treatment of depression, interferes weight loss medication that works with eating behavior in diet pills for obesity animal models, but it has not been tested in obese humans. In conclusion, hoodia Sertraline HCL ( Zoloft ), administered together with CBT, seems to be more effective in inducing weight weight loss pills for women loss in obese patients when compared with CBT alone, and therefore it could be a useful tool in the first months of CBT for severe obesity.. weight loss solutions Effects of Sertraline HCL ( Zoloft )on eating attitude and body sophisticate were similar in patients with and weight loss tablets that work without mood disorders.
3.0 /- 6.3%; p < 0.01), while a similar change in eating attitudes (evaluated through the BITE questionnaire) was observed in both groups. Sertraline HCL ( Zoloft )enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients.Serotonin reuptake inhibitors, such as dexfenfluramine, Fluoxetine ( Prozac ) and fluvoxamine, have been proposed as therapeutical tools for the treatment of eating disorders and obesity. Aim of this study is the assessment of the effects of Sertraline HCL ( Zoloft )on eating attitudes and body weight in obese patients with and without mood disorders. A consecutive series of 60 obese patients with similar characteristics, who were treated with CBT only, were used as control group. A greater reduction of BMI (mean /- SD) was observed in Sertraline HCL ( Zoloft )-treated patients when compared to controls (from 35.3 /- 5.7 to 32.0 /- 5.4 kg/m2 in Sertraline HCL ( Zoloft )-treated patients, from 37.1 /- 7.0 to 36.0 /- 7.1 kg/m2 in controls; 6.5 /- 5.4% vs.
.